NASDAQ

Fulcrum Therapeutics, Inc. (FULC)

♥ 614 Thanks from members

Live price chart, market sentiment, and community perspectives for Fulcrum Therapeutics, Inc. (NASDAQ: FULC).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Third Rock VenturesLeadership: Alex Sapir (CEO)Leadership: Tasos Gianos (CFO)Holder: Third Rock VenturesHolder: Baker Bros. AdvisorsHolder: BlackRockLosmapimodFUL-250Genetic Disease Treatments#FULC#Fulcrum Therapeutics#biotech stock#gene regulation#NASDAQ